Since the gene expression interference induced by dsRNA was discovered, dsRNA has been considered as an antiviral agent and pesticide to protect beneficial insects and crops, respectively. Recently, dsRNA was classified as IRAC mode of action group 35, and the first dsRNA pesticide, Calatha of GreenLight Bioscience, has been approved by EPA. Also an animal drug for Asian honeybee, HoneyGuard-R of Genolution is about to be approved by APQA. During the last two decades, hundreds of papers already had demonstrated the application and capability of dsRNA for agriculture, however, we have just a few commercialized products at hand at this moment. It is time to understand the processes, hurdles and limitations on the industry side that are indispensable for the development, registration and commercialization of dsRNA-based products.